Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arsenal Biosciences
Biotech
Luma locks down 15-year, $410M life sciences fund
The fund is a 15-year investment with plans to invest in groundbreaking science and support companies through discovery to commercialization.
Marissa Russo
Sep 9, 2026 9:43am
ArsenalBio sheds most of staff in pivot to in vivo CAR-T
Sep 1, 2026 9:59am
ArsenalBio halves staff amid reorganization efforts
Sep 17, 2025 4:55pm
Biotech's top money raisers: 2024
Mar 3, 2025 5:00am
Arch closes $3B-plus fund to foster biopharma upstarts
Sep 26, 2024 10:24am
ArsenalBio raises $325M, pivots away from former lead asset
Sep 4, 2024 8:00am
